TNF Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | 0 |
EBITDA | -1,796 | -2,471 | -2,188 | -1,825 |
EBIT | -1,872 | -2,471 | -2,188 | -1,825 |
Net Income | -1,796 | -1,124 | -2,064 | -1,929 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,065 | -2,640 | -764 | -3,631 |
Cash | 207 | 73 | 173 | 1,192 |
Basic Shares | 156 | 53 | 24 | 24 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | 0 |
EBITDA | -23,359 | -3,999 | -15,197 | -29,280 |
EBIT | -26,143 | -17,123 | -30,480 | -29,298 |
Net Income | -23,359 | -3,999 | -15,197 | -29,889 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,976 | -12,980 | -12,270 | -19,516 |
Cash | 173 | 2,681 | 749 | 555 |
Basic Shares | 24 | 15 | 12 | 11 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$17.66 |
2025-03-31 | -$36.23 |
2024-12-31 | -$93.22 |
2024-09-30 | -$110.98 |
